Showing results (41-50 of 149) with videos related to
Sort By:
Pageof 15
Stress and Health : Journal of the International Society for the Investigation of Stress|June 18, 2025
Longitudinal Changes in Stress and Isolation Among Multi-Ethnic Breast Cancer Survivors Throughout COVID-19Fangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.Research Square|August 23, 2023
Stress, Isolation, and Sleep Quality among Breast Cancer Survivors throughout the COVID-19 Pandemic: A Longitudinal Study in a Multi-Ethnic CohortFangyuan Zhao, Jincong Q Freeman, Nora Jaskowiak, et al.Cancer|May 10, 2018
Analyzing the clinical actionability of germline pharmacogenomic findings in oncologyRebecca Wellmann, Brittany A Borden, Keith Danahey, et al.Psycho-Oncology|October 16, 2025
Factors Associated With Fear of Cancer Recurrence in a Multiethnic Cohort of Patients With Breast CancerArmaan Jamal, Fangyuan Zhao, Jincong Q Freeman, et al.Science Advances|October 23, 2024
Single-cell chemoproteomics identifies metastatic activity signatures in breast cancerKavya Smitha Pillai, Olivia Laxton, Gang Li, et al.Investigational New Drugs|April 8, 2021
First-in-human evaluation of the novel mitochondrial complex I inhibitor ASP4132 for treatment of cancerFilip Janku, Patricia LoRusso, Aaron S Mansfield, et al.Journal of Applied Clinical Medical Physics|December 28, 2025
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapyZhen Ren, Xiaobing Fan, Milica Medved, et al.Breast Cancer Research and Treatment|June 21, 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United StatesKevin Kalinsky, Laura Spring, Clinton Yam, et al.JAMA Network Open|February 3, 2026
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER TrialJincong Q Freeman, Poornima Saha, Daniel S Peiffer, et al.Breast Cancer Research and Treatment|April 29, 2023
The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancerElizabeth Terman, Jori Sheade, Fangyuan Zhao, et al.Pageof 15